Literature DB >> 15967108

SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing.

Jun Li1, Mingjia Tan, Ling Li, Deepika Pamarthy, Theodore S Lawrence, Yi Sun.   

Abstract

Chip profiling of a p53 temperature-sensitive tumor model identified SAK (Snk/Plk-akin kinase), encoding a new member of polo-like kinases (PLKs), as a gene strongly repressed by wild-type p53. Further characterization revealed that SAK expression was downregulated by wild-type p53 in several tumor cell models. Computer search of a 1.7-kb SAK promoter sequence revealed three putative p53 binding sites, but p53 failed to bind to any of these sites, indicating that SAK repression by p53 was not through a direct p53 binding to the promoter. Transcriptional analysis with luciferase reporters driven by SAK promoter deletion fragments identified SP-1 and CREB binding sites, which together conferred a two-fold SAK repression by p53. However, the repression was not reversed by cotransfection of SP-1 or CREB, suggesting a lack of interference between p53 and SP-1 or CREB. Significantly, p53-mediated SAK repression was largely reversed in a dose-dependent manner by Trichostatin A, a potent histone deacetylase (HDAC) inhibitor, suggesting an involvement of HDAC transcription repressors in SAK repression by p53. Biologically, SAK RNA interference (RNAi) silencing induced apoptosis, whereas SAK overexpression attenuated p53-induced apoptosis. Thus, SAK repression by p53 is likely mediated through the recruitment of HDAC repressors, and SAK repression contributes to p53-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15967108      PMCID: PMC1501148          DOI: 10.1593/neo.04325

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  65 in total

1.  Late mitotic failure in mice lacking Sak, a polo-like kinase.

Authors:  J W Hudson; A Kozarova; P Cheung; J C Macmillan; C J Swallow; J C Cross; J W Dennis
Journal:  Curr Biol       Date:  2001-03-20       Impact factor: 10.834

2.  Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo.

Authors:  M D Kaeser; R D Iggo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

Review 3.  Polo-like kinases and centrosome regulation.

Authors:  Wei Dai; Qi Wang; Frank Traganos
Journal:  Oncogene       Date:  2002-09-09       Impact factor: 9.867

4.  Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein.

Authors:  G Farmer; P Friedlander; J Colgan; J L Manley; C Prives
Journal:  Nucleic Acids Res       Date:  1996-11-01       Impact factor: 16.971

5.  p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding.

Authors:  K C Lee; A J Crowe; M C Barton
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

6.  A model for p53-induced apoptosis.

Authors:  K Polyak; Y Xia; J L Zweier; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

7.  Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1.

Authors:  B Li; M Y Lee
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

8.  SSRP1 functions as a co-activator of the transcriptional activator p63.

Authors:  Shelya X Zeng; Mu-Shui Dai; David M Keller; Hua Lu
Journal:  EMBO J       Date:  2002-10-15       Impact factor: 11.598

Review 9.  Regulation of p53 downstream genes.

Authors:  W S el-Deiry
Journal:  Semin Cancer Biol       Date:  1998       Impact factor: 15.707

10.  Sak kinase gene structure and transcriptional regulation.

Authors:  J W Hudson; L Chen; C Fode; C Binkert; J W Dennis
Journal:  Gene       Date:  2000-01-04       Impact factor: 3.688

View more
  36 in total

Review 1.  Centrosomes and cancer: revisiting a long-standing relationship.

Authors:  Pierre Gönczy
Journal:  Nat Rev Cancer       Date:  2015-11       Impact factor: 60.716

Review 2.  A review of the past, present, and future directions of neoplasia.

Authors:  Alnawaz Rehemtulla; Brian D Ross
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

Review 3.  Show me your license, please: deregulation of centriole duplication mechanisms that promote amplification.

Authors:  Christopher W Brownlee; Gregory C Rogers
Journal:  Cell Mol Life Sci       Date:  2012-08-15       Impact factor: 9.261

4.  SAPK pathways and p53 cooperatively regulate PLK4 activity and centrosome integrity under stress.

Authors:  Takanori Nakamura; Haruo Saito; Mutsuhiro Takekawa
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

5.  PLK4 overexpression and its effect on centrosome regulation and chromosome stability in human gastric cancer.

Authors:  Kazuya Shinmura; Nobuya Kurabe; Masanori Goto; Hidetaka Yamada; Hiroko Natsume; Hiroyuki Konno; Haruhiko Sugimura
Journal:  Mol Biol Rep       Date:  2014-07-01       Impact factor: 2.316

Review 6.  Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy.

Authors:  Klaus Strebhardt
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

Review 7.  Once and only once: mechanisms of centriole duplication and their deregulation in disease.

Authors:  Erich A Nigg; Andrew J Holland
Journal:  Nat Rev Mol Cell Biol       Date:  2018-01-24       Impact factor: 94.444

8.  Plk1-mediated stabilization of 53BP1 through USP7 regulates centrosome positioning to maintain bipolarity.

Authors:  H Yim; S-B Shin; S U Woo; P C-W Lee; R L Erikson
Journal:  Oncogene       Date:  2016-08-01       Impact factor: 9.867

9.  Gamma-tubulin-containing abnormal centrioles are induced by insufficient Plk4 in human HCT116 colorectal cancer cells.

Authors:  Ryoko Kuriyama; Monica Bettencourt-Dias; Ingrid Hoffmann; Marc Arnold; Lisa Sandvig
Journal:  J Cell Sci       Date:  2009-05-19       Impact factor: 5.285

10.  Gene expression patterns in heterozygous Plk4 murine embryonic fibroblasts.

Authors:  Alan Morettin; Alejandra Ward; Jordan Nantais; John W Hudson
Journal:  BMC Genomics       Date:  2009-07-16       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.